The Cardiovascular Dimension of Psoriatic Arthritis
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
A Visual Guide to Cutaneous Dermatomyositis
Aligning Patient and Physician Perspectives in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
The Next Era of Psoriatic Arthritis Management
Measuring What Matters in Psoriatic Arthritis
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
Modern Approaches to Psoriatic Arthritis Management
Diagnosing Psoriatic Arthritis: A Real-World Case
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.